- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01154777
Collaborative Study Of Neurofeedback Training Of 6-18 Year Olds With Autism
October 3, 2010 updated by: Institute for Personal Excellence, P.A.
COLLABORATIVE STUDY OF NEUROFEEDBACK TRAINING OF 6-18YEAR OLDS WITH AUTISM
Neurofeedback, a neuro-cognitive training method based on operant conditioning, will be employed with 90 children with the Autistic Spectrum Disorders (ASD) over a 60 session training period to improve the limiting behavioral and sensory symptoms Autism presents (with each collaborative site working with 45 of the 90 participants).
This study seeks to demonstrate that Neurofeedback training, a non-invasive approach based on Learning Theory, will mitigate presenting symptoms of Autism, and ultimately render the person with Autism significantly more able to interact with his/her environment successfully, independently function on a day-to-day basis, and improve overall mental health.
Study Overview
Detailed Description
The specific objective is to demonstrate quantitative and qualitative improvements in functional and behavioral parameters in individuals affected by Autism Spectrum Disorders when 60 Neurofeedback training sessions are applied.
The long term objectives for these individuals include improvement of quality of daily functioning, better ability to integrate and navigate within society, and overall to decrease the limitations caused by the disability.
Additionally, increasing awareness by the public, as well as healthcare providers and legislation, that Neurofeedback is a viable intervention which may contribute not only to a significant reduction of the level of disability for affected individuals, but also in reducing required lifetime costs of healthcare.
Hopefully in the future Neurofeedback training would be incorporated as a standard of care for ASD.
As of today, there are around 1000 trained Neurofeedback practitioners in the US who are offering this intervention to a very limited number of individuals due to lack of recognition of NFB benefits.
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Magdalena M Wojdynska, M.D.
- Phone Number: 919-786-9700
- Email: magdalena@ipebraintraining.com
Study Contact Backup
- Name: Lisa Ellis
- Phone Number: 4 919-786-9700
- Email: lisae@ipebraintraining.com
Study Locations
-
-
North Carolina
-
Raleigh, North Carolina, United States, 27607
- Institute for Personal Excellence, P.A.
-
Principal Investigator:
- Magdalena M. Gebska-Wojdynska, M.D.
-
Raleigh, North Carolina, United States, 27612
- Life Quality Resources
-
Principal Investigator:
- Lucy Chartier, Ph.D., NP
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 6 to 18 year olds who have been diagnosed by their physician with mild to moderate autism, in accordance with DSM-IV diagnostic criteria
Exclusion Criteria:
- Any child with a diagnosis of Bipolar Disorder, Tourette's Syndrome, an uncontrolled seizure disorder, or a history of any major psychiatric disorder will be excluded from eligibility for the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Level of normalization of brainwaves based upon QEEG
Time Frame: Pre - training, 20 and 40 Session Interims, and post-training
|
After completion of all neurofeedback sessions, post-training evaluation will include cognitive testing, completion of ASRS and ATEC forms and a post-QEEG.
Interviews with parents will also be conducted to identify progress and changes in symptom presentation.
|
Pre - training, 20 and 40 Session Interims, and post-training
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Magdalena M Gebska-Wojdynska, M.D., Institute for Personal Excellence, P.A.
- Principal Investigator: Lucy Chartier, Ph.D., NP, Life Quality Resources
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2011
Primary Completion (Anticipated)
June 1, 2016
Study Completion (Anticipated)
December 1, 2016
Study Registration Dates
First Submitted
June 29, 2010
First Submitted That Met QC Criteria
June 30, 2010
First Posted (Estimate)
July 1, 2010
Study Record Updates
Last Update Posted (Estimate)
October 5, 2010
Last Update Submitted That Met QC Criteria
October 3, 2010
Last Verified
October 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NFB6-18Autism
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism
-
EarliTec Diagnostics, IncMarcus Autism CenterRecruitingAutism Spectrum Disorder | Developmental Delay | Autism | Autism, Early Infantile | Autism, InfantileUnited States
-
General Administration of Military Health, TunisiaMilitary Hospital of TunisRecruiting
-
Assistance Publique - Hôpitaux de ParisUnknownAutism Spectrum Disorder | Child AutismFrance
-
IRIS Media IncCompletedAutism DisorderUnited States
-
University of California, San FranciscoWithdrawn
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
Forest LaboratoriesMerz Pharmaceuticals GmbHCompletedAutism | Pediatric AutismUnited States
-
University of Medicine and Dentistry of New JerseyNational Alliance for Autism ResearchCompleted
-
Assistance Publique - Hôpitaux de ParisVille Evrard HospitalRecruitingAutism Spectrum DisordersFrance
-
Nantes University HospitalInstitut de Recherche en Santé Publique, FranceCompletedAutism Spectrum DisordersFrance
Clinical Trials on Neurofeedback training
-
University of HartfordCompleted
-
Chang Gung Memorial HospitalNot yet recruitingPost Operative Pain | Pain, Shoulder
-
University of MinnesotaCompletedDepression | Suicide, Attempted | Suicide, IdeationUnited States
-
Osaka UniversityJapan Agency for Medical Research and DevelopmentUnknown
-
Leiden University Medical CenterCompletedElevated EEG Theta/Beta Ratio
-
Quietmind FoundationCompleted
-
Stanford UniversityCompleted
-
KU LeuvenRecruiting
-
East Kent Hospitals University NHS Foundation TrustExsurgo LtdCompleted
-
NHS Greater Glasgow and ClydeCompleted